Greenbush Financial Group Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
MFSV
MFS Active Value ETF
MFSV
|
+$3.59M |
| 2 |
Vanguard Morningstar Value ETF
VTV
|
+$3.06M |
| 3 |
Vanguard Total Bond Market
BND
|
+$2.89M |
| 4 |
Capital Group Core Plus Income ETF
CGCP
|
+$2.58M |
| 5 |
Capital Group Core Bond ETF
CGCB
|
+$2.39M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Capital Group Growth ETF
CGGR
|
+$2.6M |
| 2 |
JPMorgan Active Growth ETF
JGRO
|
+$2.33M |
| 3 |
SPDR Gold Trust
GLD
|
+$2.16M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 5.75% |
| 2 | Consumer Discretionary | 2.96% |
| 3 | Communication Services | 2.18% |
| 4 | Industrials | 0.69% |
| 5 | Healthcare | 0.2% |
Similar funds
Greenbush Financial Group's Q1 2026 Portfolio in Review
As of Q1 2026, Greenbush Financial Group held 36 positions worth $302M, up 2.7% from $294M the previous quarter. Its ten largest holdings account for 66% of the portfolio.
Greenbush Financial Group deployed $16.6M of net new capital in Q1 2026, opening 2 new positions and adding to 30 existing holdings. Its largest new stake was Regeneron Pharmaceuticals: 489 shares worth $378K.
By sector, the portfolio is most concentrated in Technology at 5.8% of assets, down from 6.3% a quarter earlier, followed by Consumer Discretionary and Communication Services.
On the sell side, the largest reduction was Capital Group Growth ETF, an estimated $2.6M trimmed.
- Greenbush Financial Group's largest Q1 2026 buy was Regeneron Pharmaceuticals: 489 shares worth $378K.
- Greenbush Financial Group added most to MFS Active Value ETF in Q1 2026, an estimated $3.59M increase.
- Greenbush Financial Group's biggest Q1 2026 reduction was Capital Group Growth ETF, cutting an estimated $2.6M.
- Greenbush Financial Group's ten largest holdings make up 66% of its $302M portfolio in Q1 2026.
- Greenbush Financial Group opened 2 new positions and closed 0 in Q1 2026.
- Greenbush Financial Group's portfolio value rose 2.7% quarter-over-quarter to $302M.
Based on Greenbush Financial Group's 13F filing for Q1 2026, filed 17 Apr 2026.